Barahona M

ORCID: 0000-0002-9969-5628 · 2 papers in corpus · active 2022-2026
2026
Translational oncology ·doi:10.1016/j.tranon.2026.102712

BackgroundMost patients with ovarian cancer are diagnosed at a late stage because of the lack of early stage symptoms or effective screening methods. To address this issue, we evaluated the presence of DNA somatic variants in cervicovaginal…

2022
Journal of personalized medicine ·doi:10.3390/jpm12071074

Screenwide is a case-control study (2017−2021) including women with incident endometrial and ovarian cancers (EC and OC), BRCA1/2 and MMR pathogenic variant carriers, and age-matched controls from three centers in Spain. Participants comple…